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Abstract
The World Health Organization has recommended the scale-up of voluntary medical male 
circumcision (VMMC) for HIV prevention in sub-Saharan Africa; however, men are often 
uninterested in undergoing VMMC. The Spear & Shield project enrolled 668 men and female 
partners from ten Zambian community health centers into parallel interventions promoting 
VMMC for HIV prevention or time-matched control conditions. A mediation model was utilized 
to examine the relationships between changes in women's acceptance of VMMC and men's 
readiness to undergo the procedure. Results demonstrated that, at 12 months post-intervention, a 
5.9 % increase in the likelihood of undergoing VMMC among men in the experimental condition 
could be attributed to increased women's acceptance. From a public health perspective, involving 
women in VMMC promotion interventions such as the Spear & Shield project could significantly 
impact the demand for VMMC in Zambia.
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Introduction
Several randomized controlled trials demonstrated that voluntary medical male circumcision 
(VMMC) provides at least 60 % protection against HIV acquisition in men [1–4]. In 
response, the World Health Organization recommended that VMMC be scaled-up as an 
essential component of HIV prevention efforts in areas of high HIV prevalence, such as sub-
Saharan Africa [5]. It is estimated that widespread VMMC in Africa would avert 3.5 million 
new HIV infections by 2025, amounting to a cost savings of approximately $16.5 billion [6]. 
National efforts to promote VMMC as a HIV prevention strategy are underway in many high 
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HIV prevalence countries; however, most African ethnic groups are culturally non-
circumcising or practice "traditional" male circumcision, which may include only partial 
removal of the foreskin, non-sterile methods, and improper wound healing procedures. 
Consequently, many adult men express no interest in undergoing VMMC or allowing their 
sons to undergo VMMC [7–11]. Interventions to increase the availability and acceptability 
of VMMC for HIV prevention are therefore needed to optimize its potential benefits [12].
In addition to the benefits for men, VMMC protects female partners from STIs, cervical 
cancer, and indirectly provides protection against HIV infection in women through reduced 
male HIV prevalence [13–16]. Women report greater sexual satisfaction with circumcised 
partners, knowledge that VMMC protects against HIV, and strongly believe that VMMC 
improves health and hygiene [17, 18]. Additionally, women report that men's circumcision 
status is a salient factor when choosing sexual partners [18], and qualitative research has 
shown that the opinion of female partners can influence men's decision to undergo VMMC 
[19]. Studies have shown that women may also have reservations or misconceptions about 
VMMC, such as fear of increased promiscuity among circumcised men or the misconception 
that VMMC provides complete protection against HIV, and thus have called for women to 
be included in VMMC education programs [20, 21]. Despite this, the degree to which 
women are engaged in VMMC scale-up is unclear, and there is little data on the impact of 
women's involvement in VMMC promotion interventions [12]. Additionally, no studies have 
quantified the impact of women's support for male circumcision on men's readiness for 
VMMC.
The Republic of Zambia, identified by WHO as a priority country for VMMC scale-up, had 
completed only 32.6 % of their 2015 target of 1.9 million VMMCs as of July 2014 [22]. The 
Spear & Shield Zambia project was a bio-behavioral intervention designed to 
simultaneously increase the availability of VMMC in Zambian community health clinics 
(CHCs) and the uptake of VMMC among men who initially expressed little interest in 
undergoing the procedure. In addition, participating men were encouraged to invite their 
female partners to take part in a similar, parallel program. The study compared men 
receiving the intervention to those who received a time-matched attention control condition; 
it was hypothesized that men participating in the intervention would be more likely to 
undergo VMMC by the end of the study period as compared to those in the control 
condition. Additionally, it was hypothesized that the intervention would enhance women's 
positive attitudes and acceptability regarding VMMC, which would in turn positively 
influence their male partners to move along the behavioral continuum towards undergoing 
VMMC.
Methods
Prior to study initiation, ethical approval was obtained by the Research Ethics Committee of 
the University of Zambia School of Medicine and the Institutional Review Board at the 
University of Miami Miller School of Medicine. All study procedures were completed in 
accordance with ethical standards for human subjects research. The Spear & Shield trial 
protocol is registered on Clinicaltrials.gov, number NCT01688167.
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Participants, Procedures, and Study Conditions
Thirteen CHCs were stratified by size and HIV voluntary counseling and testing (VCT) 
volume and randomized to the intervention condition (5 clinics), a time-matched control 
condition (5 clinics), or an “observation-only” condition (3 clinics) where monthly secular 
trend data on VMMC was collected and no participants were recruited. Eligible clinics in the 
Lusaka, Zambia area were identified in consultation with the Zambian Ministry of Health 
and were selected based on: (1) ≥50 VCT participants per month, (2) no CHC personnel 
currently performing circumcisions on a regular basis, (3) ≥3 providers available at each site 
for circumcision training, and (4) ≥2 VCT counselors (or equivalent) available at each site 
for sexual risk reduction training. Providers at each clinic (doctors, nurses, or other qualified 
clinic staff members) were trained to perform VMMC and supplies for VMMC were 
continually provided to all clinics to ensure sufficient access to VMMC services across 
clinics. Intervention and control clinics each recruited a total of 8–9 cohorts of 8–10 male 
participants.
As this was a cluster randomized trial, it was initially determined that the study would utilize 
a total of 12 clinics allocated in a 1:1 ratio (experimental, control) with each clinic recruiting 
8 cohorts of 10 men for a total of 960 men. The sample size was determined by a power 
analysis which showed that the study would have at least 80 % power to detect a significant 
difference between conditions with VMMC rates of 5–10 % in the control arm, rates of 30–
40 % in the Experimental arm, and intracluster correlation coefficients (ICC) up to 0.27 
(depending on the two rates) with a two tailed test at the 0.05 level. However, due to logistic 
and staffing limitations, the total number of clinics was reduced to 10. The study power was 
re-assessed and it was determined that adequate power would be maintained with 10 clinics 
and 800 male participants. The sample size of female partners was not determined a priori, 
instead, all men were encouraged to invite their female partner to participate in a women's 
program comparable to their partner. Randomization of CHCs was conducted using a 
computer generated sequence of random numbers and was undertaken by Zambian 
investigators; trial statisticians did not participate in randomization.
Participants were recruited from VCT programs in CHCs in Lusaka, Zambia. All eligible 
participants, both experimental and control, were at least 18 years of age, HIV-negative, 
uncircumcised, and without plans to undergo VMMC in the future. Men were ineligible if 
they had plans to undergo VMMC, were HIV-positive, or had been diagnosed with a health 
condition that might preclude them from undergoing VMMC (e.g., penile cancer). 
Recruitment and enrollment were conducted in the same manner in both experimental and 
control clinics. For the purpose of this study, men were not restricted to enrolling with a 
sexual partner; female partners could also include friends or trusted advisors.
The Spear & Shield intervention was a weekly, four-session, manualized program delivered 
to men in a group format (~8–10 participants per group). The intervention was delivered by 
trained VCT counselors or nurses, and addressed issues related to HIV sexual risk reduction 
strategies. The role of VMMC in HIV risk reduction was highlighted in each of the sessions, 
including the benefits and drawbacks associated with VMMC, the VMMC procedure itself 
including the surgery and healing process, and the maintenance of sexual barrier/condom 
use following VMMC. A VMMC provider and a “spokesperson” who had previously 
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undergone VMMC spoke to the group about their experiences and answered questions. 
Women's group sessions (~6–10 females per group) were similar in content to male sessions, 
focusing on sexual risk reduction strategies and the health benefits of VMMC for their 
partners and themselves. However, neither VMMC providers nor VMMC spokespersons 
visited the women's groups. Instead, experimental condition groups included additional 
emphasis on women's issues related to HIV prevention, such as prevention of intimate 
partner violence. All control sites offered time-matched health education video sessions to 
men's and women's groups. Participants were reimbursed K10 Zambian Kwacha (~US$2) 
for travel expenses related to attendance at intervention or control sessions and compensated 
K20 (~US$4) for completing assessments.
Measures
Data was collected using an audio computer-assisted self-interview (ACASI) system. Men 
completed assessments at baseline (T1), post-intervention (T2; approximately 2 months 
post-baseline), 6 months post-intervention (T3), and 12 months post-intervention (T4). 
Women completed assessments at baseline and post-intervention (T1 and T2).
Women's VMMC Attitudes and Acceptance
VMMC attitudes and acceptance were assessed using a measure adapted from the Uganda 
National Serosurvey [23, 24]. Items related to women's acceptance included the perceived 
cultural acceptability of VMMC among women, how strongly women preferred a 
circumcised or uncircumcised sexual partner, the degree to which women would advise a 
sexual partner to undergo VMMC, and whether or not women would like their current 
partner to undergo VMMC. Items were scored such that higher scores indicated higher 
preferences and more positive attitudes towards VMMC. In this study, the above items were 
used in a measurement model as indicators of continuous latent variables representing 
women's acceptance of VMMC.
Readiness to Undergo VMMC and Uptake of VMMC
Men's readiness to undergo VMMC was assessed using the stages of change model (SOC; 
[24, 25]). Men indicated whether they had never thought about undergoing VMMC or had 
thought about it but were not considering undergoing it within the next 6 months 
(precontemplation), were considering undergoing VMMC sometime within the next 6 
months but had no specific plans to do so (contemplation), were considering undergoing 
VMMC sometime within the next 30 days and had taken a behavioral step towards the 
procedure (preparation), or had undergone VMMC (action) [26]. As this study recruited only 
uncircumcised men, no participants were in the action stage at baseline. Through the course 
of the study, participants who reported that they had undergone VMMC were verified as 
having actually undergone the procedure by study staff. Verification was completed through 
clinic record reviews (50 %), voluntary physical examinations (26 %), or VMMC provider 
interviews (24 %).
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Statistical Analyses
Although Spear & Shield enrolled a total of 800 men, as this manuscript focuses on the 
effect of female partners on men's decision to undergo VMMC, the analytic sample was 
limited to the N = 668 men who enrolled with a female partner (total N = 1336). In order to 
examine the longitudinal relationships between women's acceptance of VMMC and men's 
readiness, a cross-lagged mediation model was constructed. Latent variables representing 
women's VMMC acceptance at baseline (T1) and post-intervention (T2) were measured. 
Paths were estimated for the autocorrelations in women's acceptance and men's readiness, 
and between women's T1 acceptance and men's T2 readiness. The correlation between 
baseline acceptance and readiness was also estimated. Paths of interest for mediation 
included the effect of intervention condition on women's acceptance at T2 (the a path) and 
the effects of women's acceptance at T2 on men's readiness at T2, T3 (6 months post-
intervention), and T4 (12 months post-intervention) (the b paths; b1, b2, and b3). The direct 
effects of condition on men's readiness at T2, T3, and T4 were also estimated (the c′ paths; 
c′1, c′2, and c′3; see Fig. 1).
Estimation of the model required some restrictions on the treatment of the stages of change 
variable. Because the SOC measure is categorical with more than two levels, it would be a 
theoretically appropriate outcome variable in either an ordinal or multinomial logistic 
regression model (generally depending on the outcome of a test of proportional odds across 
levels of predictor variables). However, SOC at T2, T3, and T4 served as both outcomes and 
predictors in this path model. When the SOC is treated as a nominal variable with k 
categories and serves as a predictor, k − 1 dummy variables are needed to estimate k − 1 
relationships with an outcome. However, when the SOC is a nominal outcome, it is treated 
as a single variable with k − 1 unordered thresholds. In this path model, there was not a 
theoretically or statistically appropriate method for reconciling this difference. On the other 
hand, an ordinal variable can be treated as an indicator of a continuous latent variable having 
certain “threshold” values that result in higher categories of the observed ordinal variable. 
The continuous latent variable can serve as both a predictor (requiring no dummy variables) 
and an outcome in a path model. Thus, stages of change at T2, T3, and T4 were analyzed as 
continuous latent variables (indicated as SOC T2*, T3*, and T4* in the path model), and at 
T1, SOC was treated as a continuous covariate. This method of estimation also ensures that 
the indirect path can be correctly computed as the product of the a and b paths when the 
observed mediator(s) and outcome(s) are not measured on the same scale [27]. Figure 1 
presents a path model for this analysis; the bold lines indicate mediation paths of interest.
The model was estimated using mean- and variance-adjusted weighted least squares with 
empirical standard errors in order to control for the clustering of men within cohorts within 
clinics (n = 80 clusters). The final model was determined by comparing an unrestricted 
model to a model in which autoregressive paths were constrained to be equal over time using 
a χ2 difference test [28]. The test was significant, and the unrestricted model was retained. 
Coefficients on women's attitudes are reported as ordinary regression coefficients, and those 
on the stages of change are reported as probit regression coefficients. In addition, 
standardized coefficients were calculated according to the measurement scale of the 
predictor variable. If the predictor variable was continuous, the coefficient was calculated as 
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β = b*SD(x)/SD(y) and represents the amount of change in the outcome, in standard 
deviations, per one unit change in the standard deviation of the predictor variable, holding all 
other relationships constant. If the predictor variable was categorical (i.e., study condition), 
the standardized coefficient was calculated as β = b/SD(y) and represents the difference in 
the outcome, in standard deviations, between the experimental and control conditions, 
holding all other relationships constant.
Indirect effects were estimated as the product of a and b paths. 95 % confidence intervals for 
the indirect effects were obtained by Monte Carlo simulation, using estimated path 
coefficients and standard errors obtained from the model [it is statistically more appropriate 
to obtain confidence intervals for indirect effects empirically (e.g., using Monte Carlo or 
bootstrap methods; [29]). Monte Carlo simulation was conducted using an R macro 
developed by Selig & Preacher [30]. All other analyses were completed using MPLUS 
version 6.11 at a two-tailed level of significance of p < .05.
Results
Demographics, Attendance, and Withdrawal
Male participants (n = 668 enrolled with a female partner, n = 340 in the experimental 
condition, n = 328 in the control condition; 40 cohorts from each condition) ranged from 18 
to 57 years old (mean 27, SD = 9) with 11 ± 3 years of education. About half were 
unemployed (51 %, n = 341) and earned less than 500 ZMK (~$100) per year (53 %, n = 
354). Thirty nine percent (n = 261) were married and 40 % (n = 269) had children. Most 
(65 %, n = 436) indicated that their partner had been tested for HIV, and 9 % of those (n = 
38) reported that their partner was HIV seropositive. Female partners (n = 668) were 26 ± 8 
years old with 10 ± 3 years of education. There was 82 % agreement on marital/relationship 
status between partners, which is expected given that in this study, enrollment was not 
restricted to primary sexual partners and the demographic questionnaire did not specifically 
refer to the enrolled partner. A higher percentage of female partners had children (49 %, n = 
329). Table 1 presents further details on participant demographics.
Attendance at the intervention and control sessions was high, averaging around 90 %, and 
there were very few missed assessments. In addition, of the N = 1336 participants (n = 668 
men and 668 women), only 38 discontinued study participation. The most common reason 
for discontinuation was relocation (n = 26 participants relocated, 68 % of those withdrawn 
or lost). Figure 2 details attendance at the intervention or control sessions, assessment 
completion rates, and withdrawal/drop-out rates for each gender and study condition.
Men's Uptake of VMMC Over Time
At baseline (T1), the majority of men were in the precontemplation stage of readiness to 
undergo VMMC (n = 376, 56 %); fewer were in the contemplation (n = 208, 32 %) and 
preparation stages (n = 84, 12 %). There was no difference in baseline readiness between 
treatment conditions [X2 (2 df) = 4.72, p = .095]. By post-intervention, 6.7 % of 
experimental condition men reached the action stage (i.e., underwent VMMC) as compared 
to 2.5 % of controls. At 6 months, the proportions were 24.7 % of the experimental 
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condition vs. 11.7 % of controls. Ultimately, at 12 months follow-up, the proportions in the 
action stage were 41.4 % of men in the experimental condition and 20.9 % of controls.
Women's Acceptance of VMMC
Women's acceptance of VMMC was measured using four variables: perceived cultural 
acceptability, preference for a circumcised partner, the degree to which women would advise 
a partner to undergo VMMC, and whether or not they would like their current partner to 
undergo VMMC. Changes in these variables were measured from baseline to post-
intervention, and the results are presented in Table 2. Generally, increases in acceptance 
were noted in both conditions, with greater increases in the experimental condition.
The Impact of Women's Acceptance on Men's Readiness
A path model was fit in order to examine the relationships between condition (experimental 
vs. control), women's VMMC acceptance, and men's readiness to undergo VMMC. Model 
fit statistics indicated that the model fit the data well [Root mean square error of 
approximation (RMSEA) = .045, 95 % CI RMSEA = (.035, .055); comparative fit index 
(CFI) = .936]. Examination of the model coefficients demonstrated that, as expected, the 
autoregressive paths in women's acceptance and men's readiness to undergo VMMC were all 
significant. Additionally, women's acceptance was significantly related to men's willingness 
to undergo VMMC at baseline (r = .139, p < .001), although the path between baseline 
acceptance and T2 readiness was not significant (see Fig. 3).
The first mediation pathway of interest, the a path, was significant, such that women in the 
experimental condition reported higher acceptance at T2 (b = .389, p < .001, standardized β 
= .680). The first b path, between acceptance and stages of change at T2, was not significant 
(b = .219, p = .306, β = .110). The product of these paths, a*b1, was 0.085 with a Monte 
Carlo 95 % confidence interval including zero [CI (−.059 to .269)]. Thus, women's 
acceptance did not mediate the relationship between condition and readiness at post-
intervention (T2). At T2, men were primarily influenced by the intervention; the direct path 
between condition and readiness at T2, c′1, was significant (b = .593, p < .001; β = .516). 
The second b path, between acceptance at T2 and stages of change at T3, was also non-
significant (b = .181, p = .115, β = .080). The product a*b2 was 0.071 [Monte Carlo 95 % 
CI (−.021 to .181)]; therefore, the relationship between the intervention and men's readiness 
to undergo VMMC at 6-months follow-up (T3) was not mediated by women's acceptance.
However, the third and final b path, between women's acceptance at T2 and men's readiness 
at 12 months (T4), was significant (b = .419, p = .006, β = .158). The product a*b3 was .
163, with a Monte Carlo confidence interval that did not include zero [95 % CI (.042–.318)]. 
Thus, women's acceptance mediated the relationship between the intervention and men's 
readiness to undergo VMMC at 12 months follow-up. Figure 3 presents the path model with 
estimated unstandardized coefficients and indirect effects along with their standard errors 
and p values, and Fig. 4 presents the model with standardized coefficients.
The indirect effect a*b3 can be interpreted in the context of the predicted thresholds for the 
latent continuous variable indicating stage of change and the regression paths between 
condition, women's acceptance and SOC to demonstrate the “amount” of mediation that 
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occurred. Figure 5 shows the effects of women's acceptance on readiness among 
experimental condition participants at T3. The experimental condition is shown (1) 
including the mediation pathways (the “total effect” of condition on men's readiness) and (2) 
excluding the mediation pathways through women's acceptance (the “direct effect,” which 
does not include the mediator). As can be seen in the figure, the inclusion of the pathways 
through women's acceptance leads to a modest decrease in the expected percentage of men 
in the precontemplation and contemplation stages and an increase in the percentage of men 
in the preparation and action stages. At the action stage, the difference in percentage was 
5.9 %, indicating that an additional 5.9 % of experimental condition men were predicted to 
undergo VMMC due to the positive changes in their female partners' acceptance from 
baseline to post-intervention. Applying the difference in the expected percentage of men 
reaching the action stage to the 340 experimental condition participants, it can be estimated 
that, in this study, approximately 20 VMMCs could be attributable to the increase in 
women's acceptance (an increase of 5.9 % reaching the action stage among 340 men).
Discussion
This study examined whether some or all of the effect of an intervention to increase men's 
readiness to undergo VMMC could be attributable to enhanced female partner attitudes and 
VMMC acceptance. It was discovered that, immediately following the intervention, women's 
acceptance did not influence men's readiness; at that time, men were influenced primarily by 
the intervention itself. However, at 12 months post-intervention, improvements in women's 
attitudes and acceptance significantly influenced experimental condition men's readiness to 
undergo VMMC. At that time, an approximate 6 % increase in the likelihood of undergoing 
VMMC among experimental condition participants could be attributed to increased 
acceptance of VMMC among their female partners.
As VMMC continues to be scaled-up, it is estimated that 7 VMMCs will be needed to avert 
one case of HIV in Zambia [31], with fewer needed in areas of high HIV prevalence. Lusaka 
District, the location of this study and capital of Zambia, has the highest rates of HIV in the 
country (20.8 %; [32]). In Lusaka, progress has been made towards the goal of 80 % VMMC 
coverage by 2015 [22]. However, substantial gaps in coverage remain; the number of 
VMMCs completed in Lusaka was short of its 2012 target of ~32,000 by approximately one-
third [33]. Implementing intensive VMMC promotion interventions such as the Spear & 
Shield project and involving women could help to close this gap. Scale-up of Spear & Shield 
was designed to be feasible; for example, the intervention was nested within the existing 
post-VCT process and utilized a trained member of the pre-existing community health 
center staff to facilitate the sessions. If Spear & Shield were scaled-up to reach 10,000 men 
and women in Lusaka, it could be anticipated that approximately 3530 VMMCs would be 
performed on men participating in the program, with 600 attributable to women's 
involvement. These VMMCs could result in ~504 cases of HIV averted, 85 of which would 
be due to women's influence. Finally, the VMMCs could also indirectly result in a 
substantial reduction in HIV, STI and HPV incidence in women.
In this study, the direct impact of the intervention on men's readiness for VMMC was 
highest immediately following the sessions. It is likely that men who were most amenable to 
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undergoing VMMC were more immediately influenced, and the information and motivation 
presented during the intervention encouraged them to quickly move along the continuum 
towards VMMC. Conversely, the intervention may have had a “priming” effect on men who 
were less willing to consider VMMC immediately following the intervention, such that they 
might have become more sensitized than the control participants to the influence of their 
female partners as well as other environmental influences (e.g., media campaigns, 
community mobilization, changing social norms) on their readiness for VMMC. 
Additionally, despite the fact that “regression to the mean” is often noted in behavioral 
research, the Spear & Shield intervention continued to positively influence men indirectly 
through increasing women's acceptance 12 months after completion of the program. As has 
been found in other HIV prevention studies involving partners, targeting both members of a 
couple may lead to longer-lasting intervention effects than focusing on individuals [34–36]. 
This may be particularly salient in research on VMMC, in which the “behavior change” 
targeted by the intervention is not reversible.
This analysis was limited primarily by the inability to estimate different effects for predictor 
variables on each individual stage of change (i.e., treat SOC as a nominal variable). The 
method of analysis utilized assumes that the intervention and women's acceptance affected 
the likelihood of movement through each stage of change equally (for example, had the 
same impact on movement from precontemplation to contemplation as movement from 
contemplation to preparation), which may not have been the case. In addition, this analysis 
was unable to account for the nature of the relationship between men and their enrolled 
female partners. Enrollment of female partners was not limited to primary sexual partners, 
although sexual partners may have the most influence on men's decisions about whether to 
undergo VMMC. Future studies should examine whether “moderated mediation” occurs, 
i.e., whether partners of different types have more (or less) influence on men's decisions to 
undergo VMMC.
In summary, this study found that women's acceptance of VMMC significantly impacted 
men's decisions to undergo VMMC, supporting previous studies which underscore the 
importance of including partners in VMMC promotion efforts [17, 19]. Although women 
may have limited ability to negotiate safe sex in some African cultures [37], their 
preferences may nonetheless have a substantial influence on HIV prevention (e.g., [38, 39]). 
Thus, in order to increase the demand for and impact of VMMC, it is important to engage 
both men and women in biobehavioral interventions promoting VMMC as a potent HIV 
prevention strategy.
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Fig. 1. 
A path model showing hypothesized mediation relationships between condition, women's 
VMMC acceptance, and men's readiness to undergo VMMC. Note: VMMC voluntary 
medical male circumcision, WA women's acceptance, SOC stages of change, T1 baseline, 
T2 post-intervention (approximately 2 months post-baseline), T3 6-month follow-up, T4 12-
month follow-up
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Fig. 2. 
Attendance at the intervention or control sessions, assessment completion rates, and 
withdrawal/drop-out rates for N = 1336 men and women enrolled in the Spear & Shield 
project
Cook et al. Page 13
AIDS Behav. Author manuscript; available in PMC 2016 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 3. 
Unstandardized relationships between condition, women's VMMC acceptance, and men's 
readiness to undergo VMMC. Note Statistically significant coefficients are noted in bold; 
VMMC voluntary medical male circumcision, WA women's acceptance, SOC stages of 
change, T1 baseline, T2 post-intervention (approximately 2 months post-baseline), T3 6-
month follow-up, T4 12-month follow-up
Cook et al. Page 14
AIDS Behav. Author manuscript; available in PMC 2016 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 4. 
Standardized path coefficients between condition, women's VMMC acceptance, and men's 
readiness to undergo VMMC. Note If the predictor variable is continuous, the coefficient 
was calculated as β = b*SD(x)/SD(y) and represents the amount of change in the outcome, 
in standard deviations, per one unit change in the standard deviation of the predictor 
variable, holding all other relationships constant. If the predictor variable is categorical (i.e., 
study condition), the standardized coefficient was calculated as β = b/SD(y) and represents 
the difference in the outcome, in standard deviations, between the experimental and control 
conditions, holding all other relationships constant
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Fig. 5. 
Predicted stage of readiness for VMMC at T4, including estimates for the experimental 
condition (1) including mediation pathways through women's acceptance (indirect effect p 
= .013) and (2) excluding mediation pathways through women's acceptance, as well as the 
control condition
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Table 1
Demographic information on N = 1336 men (n = 668) and women (n = 668) enrolled in Spear & Shield
Characteristic Men M(SD)/n (%) Women
Age 27 (9) 26 (8)
Years of education 11 (3) 10 (3)
Employment status
 Employed full or part time 327 (49 %) 185 (28 %)
 Unemployed or volunteering 341 (51 %) 483 (72 %)
Annual income
 ≥500 ZMK (~$100) 314 (47 %) 278 (42 %)
 <500 ZMK 354 (53 %) 390 (58 %)
Marital status
 Married 261 (39 %) 285 (43 %)
 Not married 407 (61 %) 383 (57 %)
Children
 At least one child 269 (40 %) 329 (49 %)
 No children 399 (60 %) 339 (51 %)
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Table 2
Means/frequencies of women's acceptance variables at baseline and post-intervention
Variable Baseline M(SD)/n(%) Post-intervention Mean/percent difference (Post minus Baseline)
Perceived cultural acceptability of VMMC
1 = very unacceptable, 5 = very acceptable
 Experimental 4.14 (1.23) 4.25 (1.14) 0.11
 Control 4.07 (1.22) 4.00 (1.28) −0.07
Degree to which women would advise a partner to undergo
VMMC 1 = definitely NOT, 5 = definitely YES
 Experimental 4.21 (1.24) 4.51 (0.97) 0.30
 Control 4.19 (1.24) 4.30 (1.11) 0.11
Preference for a circumcised partner
1 = definitely NOT prefer a circumcised partner, 5 = definitely prefer a circumcised partner
 Experimental 3.44 (1.28) 3.92 (1.08) 0.48
 Control 3.22 (1.44) 3.41 (1.29) 0.19
Would like their current partner to undergo VMMC
Experimental
 Yes 274 (81 %) 317 (94 %) 13 %
 No 66 (19 %) 19 (6 %)
Control
 Yes 227 (69 %) 246 (77 %) 8 %
 No 101 (31 %) 75 (23 %)
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